Anastrozole 1 MG
Closed Solicitation Posted
- Solicitation number
- SPE2D2-20-R-0065
- Agency
- Medical Supply Chain Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
-
- Kyle Lewicki kyle.lewicki@dla.mil (445) 737-0977
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is seeking offers for Anastrozole 1 MG Tablets under Solicitation SPE2D2-20-R-0065. Anastrozole is a pharmaceutical product used in the treatment of certain types of breast cancer. The solicitation requires offerors to have the ability to manufacture, package, and deliver the tablets in accordance with applicable regulatory and quality requirements. Proposals will be evaluated on factors such as technical capability, past performance, and price. The due date for submitting offers is May 28, 2020.
This procurement is unrestricted, with no set-aside designations. The current contractor for this requirement is AVKARE LLC, who was awarded Contract SPE2D2-20-D-0101 in September 2020. The contract has been modified multiple times, most recently in August 2024 to exercise Option Year 4 for the period of September 16, 2024 through September 15, 2025. The total contract value is unknown, but the government expects to procure a specific quantity of Anastrozole 1 MG Tablets over the life of the contract. The place of performance is at the contractor's manufacturing facility.
Notice text
2 versions
Update #2 · Latest ·
Modification P00008 SPE2D220D0101 issued to invoke option year 4 for Anastrozole National Contract.
Modification P00007 SPE2D220D0101 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation.
Anastrozole 1 MG Tablets solicitation SPE2D2-20-R-0065
Update #1 ·
Anastrozole 1 MG Tablets solicitation SPE2D2-20-R-0065
Attachments
| File | Type | Posted |
|---|---|---|
| Modification P00007 SPE2D220D0101.PDF | ||
| Modification P00008 SPE2D220D0101 Option Year 4.PDF | ||
| SF30_SPE2D220D0101P00006 Signed.PDF.pdf | ||
| SPE2D220D0101 P00005 Signed.pdf | ||
| SIGNED SPE2D220D0101 P00003.PDF | ||
| Signed SPE2D220D0101P00002.pdf | ||
| SPE2D2-20-R-0065 Amendment 1 signed AvKare.pdf | ||
| Anastrozole Award SPE2D2-20-D-0101 signed.pdf | ||
| SPE2D2-20-R-0065 Final.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Anastrozole 1 MG | Solicitation | |
| Anastrozole Presolicitation | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity